DUBLIN--(BUSINESS WIRE)--The "Digital Dose Inhalers - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
The global market for Digital Dose Inhalers is estimated at US$3.2 Billion in 2023 and is projected to reach US$7.2 Billion by 2030, growing at a CAGR of 10.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Metered Dose Inhalers segment, which is expected to reach US$4.4 Billion by 2030 with a CAGR of 10%. The Dry Powder Inhalers segment is also set to grow at 11.6% CAGR over the next 8 years.
- Regional Analysis: Gain insights into the U.S. market, estimated at $1.4 Billion in 2023, and China, forecasted to grow at an impressive 13.2% CAGR to reach $669.8 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Key Market Trends & Drivers
- Digital Inhalers: A Significant Leap Forward for Respiratory Disease Management
- Asthma & Respiratory Management as Twin Goals for Digital Technology
- Respiratory Care Domain Perfectly Ripe for Adoption of Digital Devices
- Healthcare Market Enjoys Striking Leap Forward with Increasing Influx of IoT
- Number of Connected Medical Devices in Million: 2018-2025
- Digital Dose Inhaler Technology Sees Proliferation of IoT
- Advantages of the IoT-Enabled Digital Dose Inhaler
- Market to Gain from Ongoing R&D Emphasis on Advanced Treatments for Pulmonary Diseases
- Established Role of Inhaler Therapy in Respiratory Care Augurs Well
- Growing Prevalence of Asthma Provides the Perfect Platform for Market Expansion
- Role of Respiratory Inhalers in Asthma
- Asthma Rescue Inhalers Medications
- Asthma Long-Term Medications
-
Rising Prevalence of Asthma in Children Supports Growth
- Asthma Prevalence in the US by Age
- Asthma Prevalence in the US by Gender
- Asthma Prevalence in the US by Race/Ethnicity
- Slew of Smart Digital Technology & Tools for Asthma Care
-
Mounting Burden of COPD Drives Demand for Digital Dose Inhaler Technology
- COPD Stats
- Global Prevalence of COPD: Percentage of Men and Women Affected by Age Group
- Prevalence Percentage of COPD, Asthma, and Allergic Rhinitis for Select Countries
- Global Cost of Respiratory Therapy by Disease (2023E): Percentage Breakdown of Therapy Costs for Asthma, Chronic Obstructive Pulmonary Disease (COPD), Idiopathic Pulmonary Fibrosis, and Others
- Dry Powder Inhalers Set to Make Big Gains
- Green Thumbs Up with Rising Uptake of Dry Powder Inhalers
- Metered Dose Inhalers Continue to Exhibit Sustained Growth Momentum
- Smart Inhalers Come to the Fore
- Smart Inhalers Strike Right Chord with Medication Adherence Application
- Artificial Intelligence Plays Significant Role in Automation and Improving Outcomes
- Global Healthcare Artificial Intelligence Market by Application: 2023E
- Artificial Intelligence to Add Sophistication to Inhaler Technology
- New HME Method to Augment Inhaler Technology
- 3D Printing Seeks Role in Inhaler Manufacturing
- Rise in Air Pollution Levels Trigger Demand for Respiratory Devices and Inhalers
- World Ranking of Most Polluted Countries
- Percentage Share Breakdown of Global Deaths Linked to Air Pollution
- Ranking of Global Number of Deaths by Risk Factor
- Uptrend in Healthcare Spending to Result in Improved Opportunities
- Vulnerability of Growing Geriatric Population to Respiratory Diseases Enhances Prospects for Digital Inhalers
Key Questions Answered:
- How is the Global Digital Dose Inhalers Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Beximco Pharmaceuticals Ltd., 3M Company, AstraZeneca and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors Featured:
- Beximco Pharmaceuticals Ltd.
- 3M Company
- AstraZeneca PLC
- Boehringer Ingelheim International GmbH
- Cipla Ltd.
- Chiesi Farmaceutici SpA
- AptarGroup, Inc.
- Bespak Europe Ltd.
- Berry Global, Inc.
- BIOCORP
- Adherium (NZ) Limited
- Amiko Digital Health Limited
- Aerami Therapeutics
- Cognita Labs
- AireHealth
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 507 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $3.2 Billion |
| Forecasted Market Value (USD) by 2030 | $7.2 Billion |
| Compound Annual Growth Rate | 10.6% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/we25ft
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
